Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FSHR | P23945 | 6/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30769750 | 0.80 | FKBP1A (0.39) | FSHR | |
| SCHEMBL31473152 | 0.80 | FKBP1A (0.39) | FSHR | |
| SCHEMBL10641601 | 0.64 | LMNA (0.45) | KDM4EMEN1KMT2ASMN1; SMN2POLB | |
| SCHEMBL25937459 | 0.63 | CAPN1 (0.47) | KDM4EALDH1A1KMT2A | |
| SCHEMBL31758165 | 0.63 | SLC29A1 (0.44) | KDM4EMEN1ALDH1A1KMT2ATDP1 | |
| SCHEMBL1122521 | 0.62 | PTGS2 (0.64) | — | |
| SCHEMBL31473158 | 0.61 | EHMT2 (0.40) | — | |
| SCHEMBL23501067 | 0.61 | MEN1 (0.58) | KDM4EMEN1ALDH1A1KMT2ATDP1 | |
| SCHEMBL21852756 | 0.60 | TUBB4A (0.53) | MEN1ALDH1A1KMT2ASMN1; SMN2POLB | |
| SCHEMBL20707984 | 0.60 | CYP3A4 (0.42) | MEN1KMT2ATDP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119403810-A | Compounds, pharmaceutical compositions containing them and their medical use for the treatment or prevention of vascular diseases | 瓦斯塞拉股份有限公司 | 2025-02-07 | — | — | CN | disclosed |